Lifordi Gains Major Investment to Advance ADC Autoimmune Therapy
Dateline Introduction Burlington, Massachusetts — November 18, 2025 — Lifordi Immunotherapeutics has announced a strategic investment from Sanofi Ventures,...
rheumatoid arthritis
Advertisement
New 14-3-3η RA Test Expands Early Detection and Monitoring Options
Dateline IntroductionNovember 17, 2025 — Vancouver, BC & Austin, TX — Augurex Life Sciences Corp. announced the launch of...
Exagen Inc. Showcases Autoimmune Diagnostic Leadership at Q4 2025 Conferences
Dateline — CARLSBAD, Calif., November 11, 2025:Exagen Inc. (Nasdaq: XGN), a leader in autoimmune diagnostics, has announced its participation...
Advertisement
